Argos Therapeutics, Inc. Debt to Equity Ratio 2014-2018 | ARGSQ
Current and historical debt to equity ratio values for Argos Therapeutics, Inc. (ARGSQ) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Argos Therapeutics, Inc. debt/equity for the three months ending September 30, 2018 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2018-09-30 | $0.02B | $-0.01B | -1.87 |
| 2018-06-30 | $0.03B | $-0.01B | -3.06 |
| 2018-03-31 | $0.03B | $-0.00B | -7.97 |
| 2017-12-31 | $0.03B | $-0.01B | -3.25 |
| 2017-09-30 | $0.04B | $-0.02B | -2.52 |
| 2017-06-30 | $0.05B | $-0.02B | -2.26 |
| 2017-03-31 | $0.04B | $-0.01B | -3.17 |
| 2016-12-31 | $0.09B | $0.01B | 14.76 |
| 2016-09-30 | $0.09B | $0.02B | 4.40 |
| 2016-06-30 | $0.06B | $0.00B | 14.59 |
| 2016-03-31 | $0.06B | $-0.02B | -3.12 |
| 2015-12-31 | $0.06B | $-0.03B | -2.10 |
| 2015-09-30 | $0.06B | $-0.01B | -4.18 |
| 2015-06-30 | $0.04B | $0.01B | 9.35 |
| 2015-03-31 | $0.04B | $0.02B | 2.58 |
| 2014-12-31 | $0.03B | $0.03B | 1.05 |
| 2014-09-30 | $0.03B | $0.05B | 0.65 |
| 2014-06-30 | $0.01B | $0.06B | 0.23 |
| 2014-03-31 | $0.02B | $0.07B | 0.20 |
| 2013-12-31 | $0.01B | $0.04B | 0.35 |
| 2013-09-30 | $0.00B | 0.00 | |
| 2013-06-30 | $0.00B | 0.00 | |
| 2013-03-31 | $0.00B | 0.00 | |
